Share this page
Print this article
Was this page helpful?

In the News


Included below are news items from the last six months.


Experts suggest that everyone admitted to hospital should have a blood sample sent to the laboratory for measurement of glucose

19 January 2012

After wide consultation, the US Endocrine Society has suggested that all patients should have a laboratory measurement of blood glucose (blood sugar) on admission to hospital. Raised values are common, even in non-diabetics on general wards, and control of blood glucose has been shown to result in fewer complications and a shorter hospital stay.

Simple lab test is abnormal early in serious bile duct disease of newborns

16 December 2011

Biliary atresia is a rare life-threatening malformation of the bile duct that obstructs the passage of bile from the liver to the gut and causes jaundice. An operation to relieve the obstruction is needed to prevent severe liver damage and possible liver transplantation. It is more likely to be successful the earlier the diagnosis is made. In a study published in the December 2011 issue of the journal Pediatrics researchers report that babies with biliary atresia have raised blood concentrations of conjugated or direct bilirubin as early as the second or third day of life. This blood test is commonly performed in most UK laboratories and the authors suggest it might prove a useful screening test.

Rapid blood tests rule out heart attack

24 November 2011

During a heart attack, proteins called troponins are released from damaged heart muscle. If a series of sensitive troponin blood tests show no increase during the twelve hours after the onset of chest pain, a heart attack can be ruled out. A recent clinical study from Manchester Royal Infirmary has found that an undetectable sensitive troponin level in the first blood sample of the series allows heart attack to be ruled out immediately. However, patients whose blood carries an antibody to troponin can have misleadingly low test results. Recent work from Germany has strongly suggested that reliability can be improved by the addition of a second rapid test for the stress hormone copeptin.

Tests for Cancer Genes – Update

8 August 2011
We reported in a news item last year that patents held on two genes used in a lab test to assess the inherited risk of breast and ovarian cancer had been ruled invalid by a US District Court because the genes exist naturally in the body. A US Federal Appeals Court has now affirmed the validity of the patents because “isolated” gene DNA has a different molecular structure from DNA in the body.

See all news articles »